Monoclonal Antibody Given to Preterm Infants Reduces Wheezing Up to 6 Years of Age

The monoclonal antibody palivizumab significantly reduces physician-diagnosed recurrent wheezing up to six years of age.

Preterm babies are given the monoclonal antibody palivizumab to prevent respiratory syncytial virus (RSV) infection. These babies also appear less likely to develop recurrent wheeze, at least until the age of six, revealed a new research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Medicine.

In "Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing: 6 Year Follow-up Study," researchers report on multicenter case-control study of 444 Japanese infants born at 33-35 weeks gestation.

Coticosteroids Help Reduce Risk of Lung Distress in Preterm Babies
At-risk babies may benefit from steroids after 34 weeks and babies born to mothers who had a scheduled cesarean section after 37 weeks may benefit as well.

‘Preterm infants who received at least three doses of palivizumab had about half the incidence of physician-diagnosed wheeze by age six, compared to those who did not receive the drug.’

The primary goal of the study was to determine if palivizumab prophylaxis would prevent the onset of atopic asthma. The drug did not, but it did significantly reduce physician-diagnosed recurrent wheezing up to six years of age.

"Our findings suggests two independent phenotypes of recurrent wheezing in young children: one that is dependent and one that is independent of RSV lower respiratory infection," said lead study author Hiroyuki Mochizuki, professor and chairman of pediatrics at Tokai University in Japan.

The researchers found that infants who received at least three doses of palivizumab according to standard medical practice had about half the incidence of physician-diagnosed wheeze by age six, compared to those who did not receive the drug (15.3% vs. 31.6%).

'Kangaroo Care' Beats Incubators for Colombian Preterm Babies
Cesar Algeciras often spends five hours straight in the neonatal intensive care unit, lovingly clutching his premature son to his bare chest, a form of Kangaroo care

A strength of the study was that it was long-term prospective study in 52 centers with a high follow-up rate. The latter was achieved using an innovative method involving QR codes on mobile phones for photographing physician documentation of wheezing during outpatient and inpatient visits.

Study limitations include potential bias due to nonrandomized design. The authors noted that there were only minimal differences in family history of asthma, birth weight and gestational age among those who were treated and those who were not. Children in the untreated group, however, were more likely to live in a home with a smoker and have a family member with a history of allergy - factors that would increase wheezing.

Women With Bipolar Disorder at Greater Risk of Delivering Preterm Babies
Women who have been previously hospitalized for bipolar disorder are nearly twice as likely to have premature babies compared to women without a history of mental illness

"These results suggest that atopic asthma in children up to age six is probably not due to RSV, but a significant proportion of recurrent wheeze is," Dr. Mochizuki said. "Long-term observation of these subjects is planned to consider the impact of RSV infection on lung function in later life."

Source-Eurekalert

Despite Parental Sensitivity, Preterm Babies Show Bonding Difficulties
Some very preterm babies have trouble bonding with their care-givers due to neurological impairments and not to the way their parents interact with them, suggests a new study.